(Q40223070)

English

Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer

scientific article published on 5 October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 September 2017

Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer (English)

1 reference

Europe PubMed Central

18 September 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Fujita T

1

1 reference

Europe PubMed Central

18 September 2017

Timme TL

2

1 reference

Europe PubMed Central

18 September 2017

Tabata K

3

1 reference

Europe PubMed Central

18 September 2017

Naruishi K

4

1 reference

Europe PubMed Central

18 September 2017

Kusaka N

5

1 reference

Europe PubMed Central

18 September 2017

Watanabe M

6

1 reference

Europe PubMed Central

18 September 2017

Abdelfattah E

7

1 reference

Europe PubMed Central

18 September 2017

Zhu JX

8

1 reference

Europe PubMed Central

18 September 2017

Ren C

9

1 reference

Europe PubMed Central

18 September 2017

Ren C

10

1 reference

Europe PubMed Central

18 September 2017

Yang G

11

1 reference

Europe PubMed Central

18 September 2017

Goltsov A

12

1 reference

Europe PubMed Central

18 September 2017

Wang H

13

1 reference

Europe PubMed Central

18 September 2017

Vlachaki MT

14

1 reference

Europe PubMed Central

18 September 2017

Teh BS

15

1 reference

Europe PubMed Central

18 September 2017

Butler EB

16

1 reference

Europe PubMed Central

18 September 2017

Thompson TC

17

1 reference

Europe PubMed Central

18 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

5 October 2006

1 reference

Europe PubMed Central

18 September 2017

1 reference

Europe PubMed Central

18 September 2017

14

1 reference

Europe PubMed Central

18 September 2017

227-236

1 reference

Europe PubMed Central

18 September 2017

3

1 reference

Europe PubMed Central

18 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302788

0 references

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Therapeutic targets for metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Cytopathic effect of in situ gene therapy in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Interleukin-12 and the regulation of innate resistance and adaptive immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

In situ gene therapy for prostate cancer: immunomodulatory approaches

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Intensity modulated radiotherapy (IMRT) decreases treatment-related morbidity and potentially enhances tumor control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Enhanced radiation response through directed molecular targeting approaches.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Enhanced therapeutic effect of HSV-tk+GCV gene therapy and ionizing radiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Fas-Fas ligand signaling pathway mediates an interleukin-12-induced rejection of a murine prostate tumor system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Radiation Therapy—Activation of Gene Transcription and the Development of Genetic Radiotherapy: Therapeutic Strategies in Oncology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Enhancement of radiotherapy by hyperthermia-regulated gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

RTVP-1, a tumor suppressor inactivated by methylation in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

21 January 2018

Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

7 January 2021

based on heuristic

inferred from DOI database lookup

Up-regulation of Fas (CD95) in human p53wild-type cancer cells treated with ionizing radiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

7 January 2021

based on heuristic

inferred from DOI database lookup

Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo studies with interleukin-12 alone and in combination with monocyte colony-stimulating factor and/or fractionated radiation treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal scheduling of interleukin-12 and fractionated radiation therapy in the murine Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination treatment of murine tumors by adenovirus-mediated local B7/IL12 immunotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302788

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3302788

1 reference

Europe PubMed Central

18 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40223070&oldid=1889348111"